Standard
Intravenous versus Oral Etoposide : Efficacy and Correlation to Clinical Outcome in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3). / Ali, A. A.; Gronberg, M.; Hjortland, G. O.; Grønbæk, H.; Ladekarl, M.; Langer, S. W.; Welin, S.; Vestermark, L. W.; Osterlund, P.; Knigge, U.; Sorbye, H.; Janson, E. T.
2018. 184-184 Poster session presented at 15th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain.
Research output: Contribution to conference › Poster › Research › peer-review
Harvard
Ali, AA, Gronberg, M, Hjortland, GO, Grønbæk, H, Ladekarl, M, Langer, SW, Welin, S, Vestermark, LW, Osterlund, P, Knigge, U, Sorbye, H & Janson, ET 2018, 'Intravenous versus Oral Etoposide: Efficacy and Correlation to Clinical Outcome in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3)', 15th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, 07/03/2018 - 09/03/2018 pp. 184-184.
APA
Ali, A. A., Gronberg, M., Hjortland, G. O., Grønbæk, H., Ladekarl, M., Langer, S. W., Welin, S., Vestermark, L. W., Osterlund, P., Knigge, U., Sorbye, H., & Janson, E. T. (2018). Intravenous versus Oral Etoposide: Efficacy and Correlation to Clinical Outcome in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3). 184-184. Poster session presented at 15th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain.
Vancouver
Ali AA, Gronberg M, Hjortland GO, Grønbæk H, Ladekarl M, Langer SW et al. Intravenous versus Oral Etoposide: Efficacy and Correlation to Clinical Outcome in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3). 2018. Poster session presented at 15th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain.
Author
Ali, A. A. ; Gronberg, M. ; Hjortland, G. O. ; Grønbæk, H. ; Ladekarl, M. ; Langer, S. W. ; Welin, S. ; Vestermark, L. W. ; Osterlund, P. ; Knigge, U. ; Sorbye, H. ; Janson, E. T. / Intravenous versus Oral Etoposide : Efficacy and Correlation to Clinical Outcome in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3). Poster session presented at 15th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain.1 p.
Bibtex
@conference{91431abc17d147198f33e2c74fab4caf,
title = "Intravenous versus Oral Etoposide: Efficacy and Correlation to Clinical Outcome in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3)",
keywords = "chemotherapy, neuroendocrine neoplasms, intravenous, oral, survival",
author = "Ali, {A. A.} and M. Gronberg and Hjortland, {G. O.} and H. Gr{\o}nb{\ae}k and M. Ladekarl and Langer, {S. W.} and S. Welin and Vestermark, {L. W.} and P. Osterlund and U. Knigge and H. Sorbye and Janson, {E. T.}",
year = "2018",
language = "English",
pages = "184--184",
note = "15th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease ; Conference date: 07-03-2018 Through 09-03-2018",
}
RIS
TY - CONF
T1 - Intravenous versus Oral Etoposide
T2 - 15th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease
AU - Ali, A. A.
AU - Gronberg, M.
AU - Hjortland, G. O.
AU - Grønbæk, H.
AU - Ladekarl, M.
AU - Langer, S. W.
AU - Welin, S.
AU - Vestermark, L. W.
AU - Osterlund, P.
AU - Knigge, U.
AU - Sorbye, H.
AU - Janson, E. T.
PY - 2018
Y1 - 2018
KW - chemotherapy
KW - neuroendocrine neoplasms
KW - intravenous
KW - oral
KW - survival
UR - https://www.enets.org/intravenous-versus-oral-etoposide-efficacy-and-correlation-to-clinical-outcome-in-patients-with-high-grade-gastroenteropancreatic-neuroendocrine-neoplasms-who-g3.html
M3 - Poster
SP - 184
EP - 184
Y2 - 7 March 2018 through 9 March 2018
ER -
